| Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy DT Teachey, SR Rheingold, SL Maude, G Zugmaier, DM Barrett, AE Seif, ... Blood, The Journal of the American Society of Hematology 121 (26), 5154-5157, 2013 | 661 | 2013 |
| Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS–CoV-2 C Diorio, SE Henrickson, LA Vella, KO McNerney, J Chase, ... The Journal of clinical investigation 130 (11), 5967-5975, 2020 | 412 | 2020 |
| CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity E Jacoby, SM Nguyen, TJ Fountaine, K Welp, B Gryder, H Qin, Y Yang, ... Nature communications 7 (1), 12320, 2016 | 406 | 2016 |
| Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia SL Maude, SK Tasian, T Vincent, JW Hall, C Sheen, KG Roberts, AE Seif, ... Blood, The Journal of the American Society of Hematology 120 (17), 3510-3518, 2012 | 352 | 2012 |
| Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial KL Bride, T Vincent, K Smith-Whitley, MP Lambert, JJ Bleesing, AE Seif, ... Blood, The Journal of the American Society of Hematology 127 (1), 17-28, 2016 | 209 | 2016 |
| Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome DT Teachey, R Greiner, A Seif, E Attiyeh, J Bleesing, J Choi, C Manno, ... British journal of haematology 145 (1), 101-106, 2009 | 197 | 2009 |
| Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS) DT Teachey, AE Seif, SA Grupp British journal of haematology 148 (2), 205-216, 2010 | 166 | 2010 |
| mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemia DT Teachey, C Sheen, J Hall, T Ryan, VI Brown, J Fish, GSD Reid, ... Blood, The Journal of the American Society of Hematology 112 (5), 2020-2023, 2008 | 149 | 2008 |
| Checkpoint inhibitors augment CD19-directed chimeric antigen receptor (CAR) T cell therapy in relapsed B-cell acute lymphoblastic leukemia AM Li, GE Hucks, AM Dinofia, AE Seif, DT Teachey, D Baniewicz, ... Blood 132, 556, 2018 | 143 | 2018 |
| Identifying autoimmune lymphoproliferative syndrome in children with Evans syndrome: a multi-institutional study AE Seif, CS Manno, C Sheen, SA Grupp, DT Teachey Blood, The Journal of the American Society of Hematology 115 (11), 2142-2145, 2010 | 134 | 2010 |
| Pediatric leukemia predisposition syndromes: clues to understanding leukemogenesis AE Seif Cancer genetics 204 (5), 227-244, 2011 | 121 | 2011 |
| Salvage therapy with nelarabine, etoposide, and cyclophosphamide in relapsed/refractory paediatric T‐cell lymphoblastic leukaemia and lymphoma LA Commander, AE Seif, IG Insogna, SR Rheingold British journal of haematology 150 (3), 345-351, 2010 | 99 | 2010 |
| Targeting Notch signaling in autoimmune and lymphoproliferative disease DT Teachey, AE Seif, VI Brown, M Bruno, RM Bunte, YJ Chang, JK Choi, ... Blood, The Journal of the American Society of Hematology 111 (2), 705-714, 2008 | 99 | 2008 |
| The effect of pembrolizumab in combination with CD19-targeted chimeric antigen receptor (CAR) T cells in relapsed acute lymphoblastic leukemia (ALL). SL Maude, GE Hucks, AE Seif, MK Talekar, DT Teachey, D Baniewicz, ... Journal of Clinical Oncology 35 (15_suppl), 103-103, 2017 | 90 | 2017 |
| Dexrazoxane exposure and risk of secondary acute myeloid leukemia in pediatric oncology patients AE Seif, DM Walker, Y Li, YSV Huang, M Kavcic, K Torp, R Bagatell, ... Pediatric blood & cancer 62 (4), 704-709, 2015 | 83 | 2015 |
| Outcome of pediatric acute myeloid leukemia patients receiving intensive care in the United States SL Maude, JC Fitzgerald, BT Fisher, Y Li, YS Huang, K Torp, AE Seif, ... Pediatric critical care medicine 15 (2), 112-120, 2014 | 68 | 2014 |
| Noninvasive bioluminescent imaging of primary patient acute lymphoblastic leukemia: a strategy for preclinical modeling DM Barrett, AE Seif, C Carpenito, DT Teachey, JD Fish, CH June, ... Blood, The Journal of the American Society of Hematology 118 (15), e112-e117, 2011 | 68 | 2011 |
| Leveraging administrative data to monitor rituximab use in 2875 patients at 42 freestanding children's hospitals across the United States M Kavcic, BT Fisher, AE Seif, Y Li, YS Huang, D Walker, R Aplenc The Journal of pediatrics 162 (6), 1252-1258. e1, 2013 | 62 | 2013 |
| Using electronic medical record data to report laboratory adverse events TP Miller, Y Li, KD Getz, J Dudley, E Burrows, J Pennington, A Ibrahimova, ... British journal of haematology 177 (2), 283-286, 2017 | 55 | 2017 |
| Accuracy of adverse event ascertainment in clinical trials for pediatric acute myeloid leukemia TP Miller, Y Li, M Kavcic, AB Troxel, YSV Huang, L Sung, TA Alonzo, ... Journal of Clinical Oncology 34 (13), 1537, 2016 | 55 | 2016 |
